Skip to main content

Young-Hoon Park

Ewha Womans University · 医学

研究室紹介

Professor Young-Hoon Park's research lab specializes in clinical and translational research in hematology and oncology, with a focus on improving patient outcomes through advanced data-driven approaches and evidence-based clinical guidelines. The lab investigates disease prediction using machine learning and deep learning models applied to laboratory data, evaluates prognostic biomarkers such as the Advanced Lung Cancer Inflammation Index (ALI) in lymphomas, and explores treatment efficacy and safety in elderly and special populations with immune thrombocytopenia (ITP) and thrombocytopenia in pregnancy. The lab also contributes to clinical guidelines and investigates viral infections post-allogeneic stem cell transplantation, such as BK virus-associated hemorrhagic cystitis.

immune thrombocytopeniamachine learning in medicineprognostic biomarkershematologic malignanciesclinical guidelines

Research Overview

Papers
123
Total Citations
1,326
Papers (5y)
35
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
35total
2022
2023
2024
2025
2026
Citations per year (5y)
130total
20222023202420252026

Selected Papers

15
1
Article|182 citations·2021
Development of machine learning model for diagnostic disease prediction based on laboratory tests
Dong Jin Park, Min Woo Park, Homin Lee, Young-Jin Kim, Yeongsic Kim, Young Hoon Park
SJR Q1Scientific ReportsOA

The use of deep learning and machine learning (ML) in medical science is increasing, particularly in the visual, audio, and language data fields. We aimed to build a new optimized ensemble model by blending a DNN (deep neural network) model with two ML models for disease prediction using laboratory test results. 86 attributes (laboratory tests) were selected from datasets based on value counts, clinical importance-related features, and missing values. We collected sample datasets on 5145 cases,

Artificial IntelligenceComputer Science
2
Article|55 citations·2017
Prognostic Value of the Pretreatment Advanced Lung Cancer Inflammation Index (ALI) in Diffuse Large B Cell Lymphoma Patients Treated with R-CHOP Chemotherapy
Young Hoon Park, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim, Joo Han Lim
SJR Q3Acta Haematologica

<b><i>Background:</i></b> The Advanced Lung Cancer Inflammation Index (ALI, body mass index × albumin/neutrophil-to-lymphocyte ratio) has been demonstrated to be a prognostic factor of survival in some solid cancers. We retrospectively investigated the usefulness of the ALI to predict chemotherapy response and survival in 212 patients with diffuse large B cell lymphoma (DLBCL) treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) ch

OncologyMedicine
3
Article|41 citations·2016
Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study
Young Hoon Park, Hyeon Gyu Yi, Chul Soo Kim, Junshik Hong, Jinny Park, Jae Hoon Lee, Ho Young Kim, Hyo Jung Kim, Dae Young Zang, Se Hyung Kim, Seong Kyu Park, Dae Sik Hong
SJR Q3Acta Haematologica

BACKGROUND: Because many physicians seem reluctant to recommend splenectomy for elderly patients with immune thrombocytopenia (ITP), we investigated the safety and efficacy of splenectomy and the predictive factors for response in these patients. METHODS: 184 patients with primary ITP were retrospectively analyzed based on age at splenectomy: an elderly group (≥60 years, n = 52) and a younger group (<60 years, n = 132). RESULTS: There was no difference in the response rate of elderly versus youn

HematologyMedicine
4
Review|28 citations·2022
Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
SJR Q2Blood ResearchOA

Thrombocytopenia, defined as platelet count <150×10<sup>9</sup>/L, is frequently observed by physicians during pregnancy, with an incidence of approximately 10% of all pregnancies. Most of the cases of thrombocytopenia in pregnancy are due to gestational thrombocytopenia, which does not confer an increased risk of maternal bleeding. However, because other causes can be associated with life-threatening events, such as severe bleeding, that can affect to maternal and fetal outcomes, differentiatin

GeneticsMedicine
5
Review|26 citations·2022
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
Young Hoon Park, Dae‐Young Kim, Seongkoo Kim, Young Bae Choi, Dong‐Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung‐Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook, on behalf of Korean Aplastic Anemia Working Party
SJR Q2Blood ResearchOA

Despite the availability of therapies to treat patients with immune thrombocytopenia (ITP), there is currently little data from randomized trials to assist clinicians in managing patients. The evidence-based guidelines of the Korean Society of Hematology Aplastic Anemia Working Party (KSHAAWP) are intended to support patients and physicians in the management of ITP. Experts from the KSHAAWP discussed and described this guideline according to the current treatment situation for ITP in Korea and f

HematologyMedicine
6
Article|20 citations·2016
BK Virus-Hemorrhagic Cystitis Following Allogeneic Stem Cell Transplantation: Clinical Characteristics and Utility of Leflunomide Treatment
Young Hoon Park, Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim
SJR Q3Turkish Journal of HematologyOA

BKV-HC was commonly observed in patients with HC following Allo-SCT. In high-grade BKV-HC patients who fail supportive care, leflunomide may be a feasible option without significant toxicity.

OncologyMedicine
7
Article|19 citations·2016
Factor V Deficiency in Korean Patients: Clinical and Laboratory Features, Treatment, and Outcome
Young Hoon Park, Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim
SJR Q2Journal of Korean Medical ScienceOA

Due to rarity of factor V (FV) deficiency, there have been only a few case reports in Korea. We retrospectively analysed the clinical-laboratory features of FV deficiency in 10 Korean patients. Between January 1987 and December 2013, 10 case reports published in a Korean journal or proceedings of Korea Society on Thrombosis and Hemostasis were reviewed. Severity is defined as mild (> 5% of factor activity), moderate (1%-5%), and severe (< 1%). The median age at diagnosis, six males and four fema

HematologyMedicine
8
Article|19 citations·2015
Clinical efficacy and tolerability of vincristine in splenectomized patients with refractory or relapsed immune thrombocytopenia: a retrospective single-center study
Young Hoon Park, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim, Joo Han Lim
SJR Q2International Journal of Hematology
HematologyMedicine
9
Article|7 citations·1989
Surgical Results of Intermittent Exotropia.
Young Hoon Park, Myung Mi Kim
SJR Q4Journal of the Korean Ophthalmological Society
Pathology and Forensic MedicineMedicine
10
Article|5 citations·2011
The effect of the intravenous phenylephrine on the level of spinal anesthesia
Young Hoon Park, Taeha Ryu, Seong Wook Hong, Kyung Hwa Kwak, Si Oh Kim
SJR Q1Korean journal of anesthesiologyOA

BACKGROUND: Spinal anesthesia causes hypotension and bradycardia due to sympathetic nerve block and it is difficult to predict the level of sensory block and the duration of blockade. Recent studies have reported that intravenous phenylephrine can reduce the rostral spread of spinal anesthesia in pregnant women. We think a phenylephrine infusion will be useful for maintaining the baseline blood pressure by reducing the rostral spread of spinal anesthesia during the elective surgery of non-obstet

SurgeryMedicine
11
Article|5 citations·2023
Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia
Young Hoon Park, Sewon Lee, Yeung‐Chul Mun, Dong Jin Park
SJR Q1Cancer MedicineOA

BACKGROUND: Recognizing intolerance or resistance to hydroxyurea (HU), which is related to the high risk of a disease transformation and reduced survival in essential thrombocythemia (ET), is crucial to making a reasonable decision about second-line therapy. We assessed the prognostic impact of the modified European LeukemiaNet (mELN) criteria used in a recent MAJIC-ET trial by analyzing the incidence of resistance or intolerance to HU and the survival outcome compared with those of the ELN crit

GeneticsMedicine
12
Article|3 citations·2015
A Case of Disseminated Extranodal Interdigitating Dendritic Cell Sarcoma Arising from Parotid Gland
Young Hoon Park, Shin Il Kim, Suk Jin Choi, Joo Han Lim, Hyeon Gyu Yi, Moon Hee Lee, Chul Soo Kim
Kosin Medical JournalOA

Interdigitating dendritic cell sarcoma (IDCS) is an extremely rare tumor derived from professional antigen presenting cell and primarily found in lymph nodes, with rarer case report about extranodal presentation of IDCS. A 71-yr-old man was admitted with progressively enlarging and painless mass in the right parotid area for 2 months. Computed tomography of the neck and chest revealed enhancing mass in right parotid gland, multiple lymphadenopathies around neck and mediastinum, and an osteolytic

PhysiologyMedicine
13
Preprint|1 citations·2021
Safety and Tolerability of a 90-minute Infusion of Originator and Biosimilar Rituximab in Rituximab- Naïve Patients
Young Hoon Park, Yeung‐Chul Mun, Sewon Lee, Daeyoung Kim
Research SquareOA

Abstract This study aimed to investigate the safety and tolerability of 90-min rapid infusion of rituximab, originator or biosimilar (Truxima), for rituximab-naïve patients with hematologic malignancy. We undertook a retrospective review of records of 118 patients (81 originator rituximab and 37 Truxima) with hematologic malignancy who had received rituximab rapid infusion from the first cycle of chemotherapy with corticosteroid premedication administration. Most patients had high Ann Arbor stag

ImmunologyImmunology and Microbiology
14
Article|1 citations·2024
Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity
Young Hoon Park, Yeung‐Chul Mun, Sewon Lee, Yongchel Ahn
SJR Q1Journal of Clinical MedicineOA

Background and Objectives: Essential thrombocythemia (ET) is a myeloproliferative neoplasm that overproduces platelets and is associated with life-threatening thrombosis. Medical cytoreduction either with hydroxyurea (HU) or anagrelide (AG) is widely used, but drug intolerance or resistance are major concerns. Low-dose combination of HU and AG as an alternative strategy has been explored in various studies. It showed comparable response with acceptable toxicity in second-line settings for patien

GeneticsMedicine
15
Article|0 citations·1988
Production of Cephalosporin C in a Fluidized-Bed Bioreactor
Young Hoon Park, Weon Taek Seo
KRIBB Repository

Production of cephalosporin C was investigated in a fluidized-bed bioreactor using bioparticles of Cephalosporium acremonium. Bioparticles were developed by forming a biofilm of growing hyphae around celite particles which contained spores of the microorganism. Production of the antibiotic was significantly improved by using bioparticles over the free mycelial culture, possibly due to the enhanced mass transfer capacity of the bioreactor system and successive generation of highly productive morp

BiotechnologyBiochemistry, Genetics and Molecular Biology

Research Areas

GeneticsOncologyPhilosophyHematologyPathology and Forensic MedicineRadiology, Nuclear Medicine and Imaging

Young-Hoon Parkの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。